What is Dianthus Therapeutics's royalty — revenue?

Dianthus Therapeutics (DNTH) reported royalty — revenue of $0 in Q1 2026.

What does royalty — revenue mean?

This metric represents the gross revenue recognized from royalty-based arrangements associated with specific intellectual property or licensed technology, excluding any taxes collected from customers. It serves as a key indicator of the commercial viability and market adoption of the company's proprietary assets. For a clinical-stage biotechnology firm, this tracks the inflow of funds derived from licensing agreements or commercialized partnerships.

Dianthus Therapeutics DNTH Royalty — Revenue

Similar metrics at other companies

PTCTRoyalty — Revenue

$46.84M+28.5%

RGENRoyalty — Revenue (Gross)

$44K+25.7%

AXSMRoyalty — Revenue

$4.07M+269%

TEC

TECHRoyalty — Revenue

$4.97M-1.4%

VICRRoyalty — Revenue

$14.97M+39.1%

HALORoyalties — Revenue from Contract with Customer, Excluding Assessed Tax

$240.68M+43.1%

Other financials

Income statement

See full

Revenue$396.0K-81.8%

Operating income-$46.5M-40.3%

Net income-$40.8M-38.4%

EPS (diluted)-$0.85-3.7%

Balance sheet

See full

Cash & equivalents$627.7M+6,105%

Total debt$1.4M-2.3%

Total equity$1.2B+266%

Total assets$1.2B+258%

Cash flow

See full

Operating cash flow-$28.9M-4.4%

CapEx$10.0K-58.3%

Free cash flow-$28.9M-4.4%

Valuation

See full

Market cap$4.51B+662%

Enterprise value$3.88B+565%

P/S1,465.1×+962×

Profitability

See full

Operating margin-4,558.4%-9,354pp

Net margin-4,104.8%-7,304pp

FCF margin-3,561.6%-6,956pp

Returns & leverage

See full

Return on equity-28.6%+3.2pp

Debt / equity0×0.0×

Current ratio29.3×+13.3×

Where this comes from

Reported directly by Dianthus Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Dianthus Therapeutics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Dianthus Therapeutics's royalty — revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Dianthus Therapeutics's royalty — revenue?: Dianthus Therapeutics (DNTH) reported royalty — revenue of $0 in Q1 2026.
What does royalty — revenue mean?: This metric represents the gross revenue recognized from royalty-based arrangements associated with specific intellectual property or licensed technology, excluding any taxes collected from customers. It serves as a key indicator of the commercial viability and market adoption of the company's proprietary assets. For a clinical-stage biotechnology firm, this tracks the inflow of funds derived from licensing agreements or commercialized partnerships.